139 related articles for article (PubMed ID: 29947529)
1. Increased endothelin-1-mediated vasoconstrictor tone in human obesity: effects of gut hormones.
Schinzari F; Tesauro M; Cardillo C
Physiol Res; 2018 Jun; 67(Suppl 1):S69-S81. PubMed ID: 29947529
[TBL] [Abstract][Full Text] [Related]
2. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
Schinzari F; Tesauro M; Cardillo C
J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
[TBL] [Abstract][Full Text] [Related]
3. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
Dow CA; Stauffer BL; Brunjes DL; Greiner JJ; DeSouza CA
Exp Physiol; 2017 Sep; 102(9):1133-1142. PubMed ID: 28635124
[TBL] [Abstract][Full Text] [Related]
4. Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity.
Schinzari F; Tesauro M; Veneziani A; Mores N; Di Daniele N; Cardillo C
Hypertension; 2018 Jan; 71(1):185-191. PubMed ID: 29203627
[TBL] [Abstract][Full Text] [Related]
5. Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target.
Schinzari F; Cardillo C
Can J Physiol Pharmacol; 2020 Sep; 98(9):563-569. PubMed ID: 32808824
[TBL] [Abstract][Full Text] [Related]
6. The vascular endothelin system in obesity and type 2 diabetes: pathophysiology and therapeutic implications.
Campia U; Tesauro M; Di Daniele N; Cardillo C
Life Sci; 2014 Nov; 118(2):149-55. PubMed ID: 24607780
[TBL] [Abstract][Full Text] [Related]
7. Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats.
Eringa EC; Stehouwer CD; Roos MH; Westerhof N; Sipkema P
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1134-9. PubMed ID: 17623751
[TBL] [Abstract][Full Text] [Related]
8. Gut Peptide Agonism in the Treatment of Obesity and Diabetes.
Grandl G; Novikoff A; DiMarchi R; Tschöp MH; Müller TD
Compr Physiol; 2019 Dec; 10(1):99-124. PubMed ID: 31853954
[TBL] [Abstract][Full Text] [Related]
9. New Targets for Drug Treatment of Obesity.
Valsamakis G; Konstantakou P; Mastorakos G
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():585-605. PubMed ID: 28061687
[TBL] [Abstract][Full Text] [Related]
10. Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome.
Schinzari F; Tesauro M; Rovella V; Di Daniele N; Mores N; Veneziani A; Cardillo C
J Clin Endocrinol Metab; 2013 Mar; 98(3):1235-41. PubMed ID: 23372172
[TBL] [Abstract][Full Text] [Related]
11. Gut hormones as therapeutic agents in treatment of diabetes and obesity.
Tan T; Bloom S
Curr Opin Pharmacol; 2013 Dec; 13(6):996-1001. PubMed ID: 24060699
[TBL] [Abstract][Full Text] [Related]
12. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
13. Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity.
Rovella V; Rodia G; Di Daniele F; Cardillo C; Campia U; Noce A; Candi E; Della-Morte D; Tesauro M
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33668627
[TBL] [Abstract][Full Text] [Related]
14. Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.
Lteif AA; Fulford AD; Considine RV; Gelfand I; Baron AD; Mather KJ
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1510-7. PubMed ID: 18957616
[TBL] [Abstract][Full Text] [Related]
15. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery.
Holst JJ
Curr Opin Pharmacol; 2013 Dec; 13(6):983-8. PubMed ID: 24161809
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance, obesity and the metabolic syndrome. Is there a therapeutic role for endothelin-1 antagonists?
Shaw SG; Boden PJ
Curr Vasc Pharmacol; 2005 Oct; 3(4):359-63. PubMed ID: 16248779
[TBL] [Abstract][Full Text] [Related]
17. Endothelin A (ET(A)) receptors are involved in augmented adrenergic vasoconstriction and blunted nitric oxide-mediated relaxation of penile arteries from insulin-resistant obese zucker rats.
Sánchez A; Contreras C; Martínez P; Muñoz M; Martínez AC; García-Sacristán A; Hernández M; Prieto D
J Sex Med; 2014 Jun; 11(6):1463-74. PubMed ID: 24697908
[TBL] [Abstract][Full Text] [Related]
18. New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus.
Pernow J; Shemyakin A; Böhm F
Life Sci; 2012 Oct; 91(13-14):507-16. PubMed ID: 22483688
[TBL] [Abstract][Full Text] [Related]
19. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease.
Böhm F; Pernow J
Cardiovasc Res; 2007 Oct; 76(1):8-18. PubMed ID: 17617392
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
